Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 136, 2016 - Issue 7
Submit an article Journal homepage
379
Views
9
CrossRef citations to date
0
Altmetric
Original Article

The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma

Miia SeppäläHaartman Institute, University of Helsinki, Helsinki, Finland; Correspondence[email protected]
,
Elina HalmeDepartment of Otorhinolaryngology, Tampere University Hospital, Tampere, Finland;
,
Lauri TiilikainenDepartment of Pathology, University of Tampere, Tampere, Finland;
,
Annika LuukkainenHaartman Institute, University of Helsinki, Helsinki, Finland;
,
Jussi LaranneDepartment of Otorhinolaryngology, Tampere University Hospital, Tampere, Finland;
,
Markus RautiainenDepartment of Otorhinolaryngology, Tampere University Hospital, Tampere, Finland;
,
Heini HuhtalaSchool of Health Sciences, University of Tampere, Tampere, Finland;
,
Timo PaavonenDepartment of Pathology, University of Tampere, Tampere, Finland; ;Fimlab Laboratories Ltd, Tampere, Finland;
&
Sanna Toppila-SalmiHaartman Institute, University of Helsinki, Helsinki, Finland; ;Department of Allergy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
 show all
Pages 729-735 | Received 01 Dec 2015, Accepted 25 Jan 2016, Published online: 16 Mar 2016

References

  • Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309–16.
  • Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol 2010;46:636–43.
  • Almangush A, Bello IO, Keski–Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, et al. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early‐stage oral tongue cancer. Head Neck 2014;36:811–18.
  • Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 2013;34:137–43.
  • Prendergast GC, Chang MY, Mandik-Nayak L, Metz R, Muller AJ. Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases. Curr Med Chem 2011;18:2257–62.
  • Löb S, Königsrainer A. Role of IDO in organ transplantation: promises and difficulties. Int Rev Immunol 2009;28:185–206.
  • Prendergast GC, Metz R, Muller AJ. Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway. Am J Pathol 2010;176:2082–7.
  • Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006;12:1144–51.
  • Ino K, Yoshida N, Kajiyama H, Shibata K, Yamamoto E, Kidokoro K, et al. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer 2006;95:1555–61.
  • Ryan M. FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients. Am J Otolaryngol 2014;35:689–694.
  • Seppälä M, Tervo S, Pohjola K, Laranne J, Huhtala H, Toppila‐Salmi S, et al. The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma. Apmis 2015;123:1007–15.
  • Novitskiy SV, Moses HL. Turn off the IDO: will clinical trials be successful? Cancer Discov 2012;2:673–5.
  • Li M, Bolduc AR, Hoda MN, Gamble DN, Dolisca SB, Bolduc AK, et al. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma. J Immunother Cancer 2014;2:1426–2-21. eCollection 2014.
  • Bonomi M, Patsias A, Posner M, Sikora A. The Role of Inflammation in Head and Neck Cancer. In: Anonymous Inflammation and Cancer. Basel: Springer; 2014, p. 107–127.
  • Erreni M, Bianchi P, Laghi L, Mirolo M, Fabbri M, Locati M, et al. Expression of chemokines and chemokine receptors in human colon cancer. Meth Enzymol 2009;460:105–21.
  • Skipworth RJ, Moses AG, Sangster K, Sturgeon CM, Voss AC, Fallon MT, et al. Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer. Support Care Cancer 2011;19:391–401.
  • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–99.
  • Zhang Z, Han Y, Song J, Luo R, Jin X, Mu D, et al. Interferon‐γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2, 3‐dioxygenase activity. J Oral Pathol Med 2015;44:15–27.
  • Laimer K, Troester B, Kloss F, Schafer G, Obrist P, Perathoner A, et al. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas. Oral Oncol 2011;47:352–7.
  • Katz JB, Muller AJ, Prendergast GC. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 2008;222:206–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.